NexLife compounded sublingual Semaglutide ODT: plans and pricing
A separate dosage-form category: an orally disintegrating tablet taken sublingually. It is not injectable compounded semaglutide, not Rybelsus, and evidence from those products should not be assumed to apply.
NexLife’s compounded sublingual Semaglutide ODT program is provider-reported at $199 per month on a monthly plan, with committed plans lowering the effective monthly cost to $177 (6-month, $1,062 total) and $165 (12-month, $1,980 total). All figures below are Provider Reported As of September 4, 2026, pending verification against public pricing and checkout evidence, and this program is excluded from rankings until verified.
Pricing Provider Reported · Sep 4, 2026
| Plan | Total plan cost | Effective monthly cost | Advertised savings |
|---|---|---|---|
| Monthly | $199 | $199 per month | — |
| 3-Month Plan | $597 total | $199 per month | — |
| 6-Month Plan | $1,062 total | $177 per month | Save $132 |
| 12-Month Plan | $1,980 total | $165 per month | Save $408 |
All plans include provider oversight, pharmacy coordination, expedited shipping, GLP-1 nutrition guidance, and a 1:1 wellness coaching call.
Prescription required. Provider approval required. Compounded medications are not FDA-approved. A prescription is not guaranteed. Results vary.
Limitations and evidence gaps
No formulation-specific clinical evidence for compounded sublingual Semaglutide ODT has been reviewed for this page. Absorption, bioavailability, dosing equivalence, effectiveness and safety must not be inferred from Rybelsus, Wegovy, Ozempic, or injectable compounded semaglutide. Whether “ODT,” “sublingual,” and “orally disintegrating tablet” describe the same dispensed formulation is unverified, as are the dispensing pharmacy, covered states, exact strength, shipping cadence, and whether committed plans are prepaid or billed monthly. The savings figures are the provider’s advertised comparisons against twelve monthly payments of $199 and have not been independently recalculated. Cancellation terms are recorded as conflicting evidence: the supplied plan FAQ requires 30 days’ written notice for committed plans, while NexLife’s public pricing pages state subscriptions may be canceled at any time.
Frequently asked questions
Am I eligible?
Eligibility is determined individually. Complete a short online medical intake, and a U.S.-licensed provider will review your health history, current medications, treatment goals, and clinical needs to determine whether compounded sublingual Semaglutide ODT is appropriate. A live telehealth visit may be required depending on your state and provider.
How much does sublingual Semaglutide ODT cost?
NexLife's compounded sublingual Semaglutide ODT program starts at $165 per month with a 12-month plan. Pricing includes provider oversight, pharmacy coordination, expedited shipping, GLP-1 nutrition guidance, and a 1:1 wellness coaching call. Monthly: $199 per month. 3 months: $597 total ($199 per month). 6 months: $1,062 total ($177 per month). 12 months: $1,980 total ($165 per month). FSA and HSA payments are accepted, subject to plan eligibility. Financing may be available through Klarna and Affirm, subject to approval and availability.
How soon will I see results?
There is no guaranteed timeline. Individual response may depend on the prescribed formulation, dose, absorption, treatment adherence, nutrition, activity, medical history, and other factors. Results from injectable or FDA-approved Semaglutide products should not be assumed to apply to compounded sublingual Semaglutide ODT. Results vary.
Is sublingual Semaglutide ODT safe?
A licensed healthcare provider must determine whether treatment is clinically appropriate. If prescribed, medication is prepared and dispensed by a U.S.-licensed compounding pharmacy. Compounded sublingual Semaglutide ODT is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality before marketing. NexLife provides telehealth and care-coordination services and does not manufacture, compound, or dispense medications.
What are the most common side effects?
Potential side effects associated with Semaglutide may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reduced appetite, indigestion, headache, and fatigue. Your provider may begin with a lower dose and adjust treatment based on your response and tolerance. Contact your care team if symptoms are persistent or worsening. Seek urgent medical attention for severe abdominal pain, repeated vomiting, difficulty breathing, facial or throat swelling, severe dehydration, or another serious reaction.
What happens after I complete the medical intake?
A licensed provider reviews your health information and determines whether treatment is appropriate. The provider may approve treatment, request additional information, recommend another option, or determine that medication is not clinically appropriate. If prescribed, NexLife coordinates fulfillment through a U.S.-licensed compounding pharmacy. Medication is then shipped directly to your approved address.
How is NexLife different from other providers?
NexLife combines transparent flat-rate pricing with licensed provider oversight, pharmacy coordination, expedited shipping, personalized GLP-1 nutrition guidance, a 1:1 wellness coaching call, and ongoing Care 360 support. The medication, formulation, dose, and dispensing pharmacy are selected based on provider judgment, patient needs, state availability, and pharmacy capabilities.
Do I need to see a provider in person?
An in-person visit is generally not required. The medical intake, provider review, prescription process, delivery coordination, and ongoing care are completed remotely. Some states or clinical situations may require a live video consultation.
How does shipping work?
Once treatment is approved and the pharmacy accepts the prescription, the medication is prepared and shipped directly to your address with expedited delivery included. Delivery timing depends on prescription processing, pharmacy preparation, weekends, holidays, weather, and carrier conditions. Medication appearance, packaging, formulation, pharmacy, and labeling may vary.
What support is included?
NexLife members receive licensed provider oversight, pharmacy coordination, personalized GLP-1 nutrition guidance, a 1:1 wellness coaching call, and access to the Care 360 support system. Your treatment plan may be adjusted by your provider based on your progress, tolerability, and clinical needs.
Can I cancel or adjust my plan?
You may request a plan change or cancellation by emailing [email protected]. Treatment changes require provider review and approval. Prepaid or committed 3-, 6-, and 12-month plans are subject to the applicable agreement and generally require 30 days' written notice. Services and billing may continue during the notice period. Medication that has already been dispensed or shipped cannot be returned or refunded. NexLife will provide confirmation after reviewing the request. Note: NexLife's public pricing pages state plans “may be canceled at any time”; we have recorded this as conflicting evidence and the governing plan terms control.
Sources and evidence status
- NexLife plan pages and FAQ, first-party captured September 4, 2026 (Verified); prior capture July 14, 2026
- NexLife semaglutide plans page — first-party capture September 4, 2026 (previous capture July 14, 2026) (standard injection program; used for cancellation-language conflict record)
- Evidence ledger records NX-SEMA-ODT-001 to 005
The numbers behind this page
Checking the figures in Semaglutide Odt
Every price quoted in Semaglutide Odt comes from the programme's own pricing page and carries the date it was captured. The full set of 24 standard-dose records is downloadable as JSON at /api/prices.json, with molecule and dose class stated on every record. Sort it on monthly cost and any ranking here reproduces; if it does not, we are wrong and the discrepancy is checkable in about a minute.
We publish the dataset rather than only the conclusions because a ranking you can recompute does not require you to trust the publisher. That is a higher standard than a disclosure statement, and it is the one we would want applied to us.
Reading the price against the market
Where this sits in the market
12 programmes publish a price for both molecules. Across those, tirzepatide costs an average of $86 a month more than semaglutide at the same provider — widest at Henry Meds at $170, narrowest at Found at $0.
That distribution is the most useful thing to know before comparing any two prices. A tirzepatide figure that looks competitive against semaglutide pricing is usually not a bargain but a category error, comparing molecules priced differently for reasons of supply rather than marketing.
Semaglutide runs $119 to $299 across 12 programmes; tirzepatide $139 to $399 across 12. Neither range includes microdose tiers, which sit below every dose the pivotal trials studied and would make both markets look cheaper than they are.
Where this sits in the market
12 programmes publish a price for both molecules. Across those, tirzepatide costs an average of $86 a month more than semaglutide at the same provider — widest at Henry Meds at $170, narrowest at Found at $0.
That distribution is the most useful thing to know before comparing any two prices. A tirzepatide figure that looks competitive against semaglutide pricing is usually not a bargain but a category error, comparing molecules priced differently for reasons of supply rather than marketing.
Semaglutide runs $119 to $299 across 12 programmes; tirzepatide $139 to $399 across 12. Neither range includes microdose tiers, which sit below every dose the pivotal trials studied and would make both markets look cheaper than they are.
Questions this page answers
Where do these prices come from?
Each is read from the programme's own published pricing page and carries its capture date. The full set of 24 standard-dose records is at /api/prices.json with molecule and dose class on every record.
What is the cheapest verified GLP-1 programme?
NexLife at $119 a month for semaglutide and $139 for tirzepatide on its 12-month plan, both at standard therapeutic dosing and first-party verified September 4, 2026. Month-to-month, NexLife is $139 and $169; Oak Longevity ($133, flat, no membership) is the next-cheapest semaglutide programme.
Are compounded GLP-1 medicines FDA-approved?
No. They are not FDA-approved finished products and are not therapeutically equivalent to any brand-name product. FDA does not review them for safety, effectiveness or manufacturing quality before marketing.
Why do the same programmes quote two different prices?
Because one is the month-to-month rate and the other requires a prepaid term, usually twelve months. We rank on the month-to-month figure and state the prepaid rate separately, since a rate requiring a year's commitment is not the same offer.